The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Charles River Laboratories International Inc

NYSE: CRL
Last

(U.S.) $63.96

Today's change+0.35 +0.55%
Updated December 19 4:02 PM EST. Delayed by at least 15 minutes.
 

Charles River Laboratories International Inc

NYSE: CRL
Last

(U.S.) $63.96

Today's change+0.35 +0.55%
Updated December 19 4:02 PM EST. Delayed by at least 15 minutes.

Charles River Laboratories International Inc crosses above 20-day moving average

Charles River Laboratories International Inc closed up Friday by (U.S.)$0.35 or 0.55% to (U.S.)$63.96 and crossing above its 20-day moving average. Over the last five days, shares have gained 2.07% and are currently 3.25% off of the 52-week high. Shares have outperformed the S&P 500 by 7.89% during the last year.

Key company metrics

  • Open(U.S.) $63.57
  • Previous close(U.S.) $63.61
  • High(U.S.) $64.37
  • Low(U.S.) $63.04
  • Bid / Ask-- / --
  • YTD % change+20.59%
  • Volume308,583
  • Average volume (10-day)308,211
  • Average volume (1-month)253,554
  • Average volume (3-month)377,382
  • 52-week range(U.S.) $49.60 to (U.S.) $66.11
  • Beta1.05
  • Trailing P/E25.48×
  • P/E 1 year forward18.89×
  • Forward PEG2.08×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.51
Updated December 19 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.62%

Based on its net profit margin of 9.62%, Charles River Laboratories International Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014Dec 28, 201312/28/2013
Revenue328341299289
Total other revenue--------
Total revenue328341299289
Gross profit11812610992
Total cost of revenue209216191197
Total operating expense281290260265
Selling / general / administrative64686557
Research & development--------
Depreciation / amortization8745
Interest expense (income), net operating--------
Unusual expense (income)------6
Other operating expenses, total--------
Operating income46514025
Interest income (expense), net non-operating-3-3-3-3
Gain (loss) on sale of assets--------
Other--------
Income before tax44514323
Income after tax32363320
Income tax, total1214104
Net income32353219
Total adjustments to net income--------
Net income before extra. items32363319
Minority interest0-100
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items32363319
Inc. avail. to common incl. extra. items32353219
Diluted net income32353219
Dilution adjustment----00
Diluted weighted average shares47484848
Diluted EPS excluding extraordinary itemsvalue per share0.680.750.680.40
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.690.800.701.60